- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
English
Views: 170 Author: Site Editor Publish Time: 2024-07-22 Origin: Site
AVO Biotech and UPM University Malaysia announced a comprehensive strategic cooperation in mRNA vaccines!
Recently, AVO Biotech Pte. Ltd. which is Jiangsu Synthgene Biotechnology Co., Ltd's Southeast Asia Branch and Universiti Putra Malaysia signed an MOU agreement for a strategic cooperation. Both parties target the mRNA industry's market need, maximizing their respective advantages and characteristics, and collaborating extensively in the field of mRNA new vaccines in order to produce a win-win situation for industry and academic!
On July 19, 2024, Lei Bo, CMO of AVO Biotech Pte. Ltd, and AVO's delegation visited the School of Veterinary Medicine, School of Medicine, Innovation Center, and Foreign Cooperation Center of UPM University in Malaysia. The two parties conducted in-depth discussions on how to promote mRNA vaccine technology cooperation and signed the MOU strategic cooperation agreement.
Mr. Leo, CMO of Synthgene Southeast Asia Branch said
" We are very pleased to collaborate with UPM, which is the second-ranked public university in Malaysia and the first in the field of veterinary medicine. As a supplier of mRNA vaccine raw materials and solutions with core technologies, Synthgene can not only provide high-quality raw materials for UPM's innovative mRNA vaccine projects, but Synthgene also has experience in R&D and research of multiple mRNA human vaccines/veterinary vaccines and Proven solution. We are looking forwards to the comprehensive cooperation with UPM in the field of mRNA vaccines. We will be bringing more innovative vaccine products to Malaysia by using the advantages of both parties in basic research, clinical trials, process transformation, and industrialization to accelerate the research and development of innovative mRNA vaccines bringing more innovative vaccine products to Malaysia. "
Dr.GOH Yong Meng, Dean of UPM University of Veterinary Medicine said
" Currently, our own team is preparing to establish a small-scale vaccine experimental factory with GMP standards. We are very much looking forward to joint research with Shenji in the field of veterinary mRNA vaccines, and at the same time, we will complete the preparations for the establishment of a GMP factory and other cooperation. This will greatly promote Malaysia. Development of veterinary vaccines. UPM University School of Veterinary Medicine has excellent resources in the veterinary field and is also the number one veterinary school in Malaysia. We are very confident that through cooperation between the two parties, we will contribute to the field of veterinary research in Malaysia. "
Dr.Rukman Awang Hamat, Vice Dean of the UPM School of Medicine said
"We have already carried out clinical research on some products in the field of human health with Shenji Biologics, and human mRNA vaccines will continue to be studied as a new project. We are very pleased to share the R&D platform and resources of the medical school with Schengene, and at the same time assist Schengene in completing the project approval of related human mRNA vaccine products in Malaysia."
Prof. Dr. SAMSILAH ROSLAN, Chairman of UPM Innovation Center said
"mRNA technology is a very good innovative therapy. In the future, there will be more vaccine research projects that can be connected. We will give full support and help to the projects from the school level, and jointly apply for government projects and support funds. We hope that both parties can work together. Do a good job in research on new mRNA projects and jointly develop more new achievements in mRNA technology."
Dr. ABDUL LATIF BIN ANUAR, Chairman of UPM Foreign Cooperation Center said
"Thank you very much for the arrival of Shenji Biotech with its new mRNA project technology. We need to introduce more new technologies to be implemented in Malaysia so that we can better contribute to the development of human and animal health. UPM University has a great basic and innovative research team, and hopes to develop more mRNA vaccine products through the platform established by both parties, and contribute to the common benefit of Malaysia and other countries around the world. At the same time, it will also fully cooperate and facilitate the entry of other Schengene products into Malaysia. The market provides necessary help."
Universiti Putra Malaysia ("UPM" or "UPM" for short) was founded in 1931 and is located in Serdang, Selangor, Malaysia. It is a famous comprehensive research university in Southeast Asia and a foreign-related supervision network of the Chinese Ministry of Education. Recognized formal foreign institutions. Universiti Putra has a long-standing reputation for excellence in education and research and is one of the world's top public universities recognized in the international academic field. BoDa's agriculture, forestry, veterinary medicine, chemical environment and other majors rank among the top 100 QS World University disciplines, ranking 158th in the 2024 QS World University Rankings.
